Comparing the Efficacy, Safety, and Superiority of Calcitonin Gene-Related Peptide Monoclonal Antibodies and Botox in Preventing and Treating Migraines.

Autor:	Siddiqui M; Neurology, St. George's University, True Blue, GRD.; Neurology, California Institute of Behavioral Neurosciences & Psychology, Fairfield, USA., Shah PV; Medicine, California Institute of Behavioral Neurosciences & Psychology, Fairfield, USA., Balani P; Internal Medicine, California Institute of Behavioral Neurosciences & Psychology, Fairfield, USA., Lopez AR; Psychiatry, California Institute of Behavioral Neurosciences & Psychology, Fairfield, USA., Nobleza CMN; Neurology, California Institute of Behavioral Neurosciences & Psychology, Fairfield, USA., Khan S; Internal Medicine, California Institute of Behavioral Neurosciences & Psychology, Fairfield, USA.
Jazyk:	angličtina
Zdroj:	Cureus [Cureus] 2021 Jan 30; Vol. 13 (1), pp. e13002. Date of Electronic Publication: 2021 Jan 30.
DOI:	10.7759/cureus.13002
Abstrakt:	Both calcitonin gene-related peptide (CGRP) monoclonal antibodies (mAbs) and OnabotulinumtoxinA (botox) are used in the prevention of chronic migraines. However, it is not clear which is more effective overall. This review will compare the efficacy, side effects, cost-effectiveness, and other factors between CGRP mAbs and botox. We searched Pubmed and Google Scholar using the keywords migraines, CGRP mAbs, botox, efficacy, side effects, aura. All articles, including case-control/cohort studies, case series, case reports, randomized control trials, traditional/systematic reviews, were analyzed. CGRP mAbs and botox both reduce the frequency of migraines in patients. Patients have reported they decreased migraines' frequency and intensity in several studies after being given each medication. While CGRP mAbs are more recent medications, botox has been studied for more than a decade as a migraine preventative. Both drugs have minor short-term side effects, but some CGRP mAbs may cause persistent constipation too. CGRP mAbs are self-injected every month, and botox is physician-injected every three months, making it easier to stay compliant. While both medications are expensive, botox has a lower cost over time. Botox is more effective prophylaxis of migraines based on the articles that were reviewed. While both CGRP mAbs and botox are efficacious and tolerable, botox has been studied longer, has fewer side effects, is more cost-effective, and is easier to comply with. Competing Interests: The authors have declared that no competing interests exist. (Copyright © 2021, Siddiqui et al.)
Databáze:	MEDLINE
Externí odkaz:	Zobrazit plný text záznamu